{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:25:18Z","timestamp":1770524718106,"version":"3.49.0"},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.5414\/cpp43007","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T03:51:30Z","timestamp":1301025090000},"page":"7-11","source":"Crossref","is-referenced-by-count":80,"title":["Infliximab in chronic ocular inflammation"],"prefix":"10.5414","volume":"43","author":[{"given":"R.P.","family":"Baughman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.E.","family":"Lower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T05:45:17Z","timestamp":1378446317000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dustri.com\/article_response_page.html?artId=1254&doi=10.5414\/CPP43007&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":0,"journal-issue":{"issue":"01","published-print":{"date-parts":[[2005]]}},"alternative-id":["43007"],"URL":"https:\/\/doi.org\/10.5414\/cpp43007","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1,1]]}}}